Examkin

Soru

Zorluk: KolayBipolar and Related Disorders

A 20-year-old university student presents to the student health center complaining of severe fatigue, hypersomnia, and a deeply depressed mood over the past three weeks. Review of his medical records reveals a prior hospitalization during his freshman year for an episode characterized by pressured speech, grandiosity, and severe insomnia lasting for ten days. He is currently unmedicated. Which of the following pharmacological options are appropriate for managing this patient's current condition? (Select all that apply)

  1. QuetiapineCevap
  2. B
    Sertraline monotherapy
  3. LurasidoneCevap
  4. D
    Escitalopram monotherapy
  5. E
    Fluoxetine combined with phenelzine

Cevap

The appropriate pharmacological options for this patient are quetiapine and lurasidone.
The correct answers identify second-generation antipsychotics that are FDA-approved as first-line monotherapies for acute bipolar depression. The patient's history of a manic episode requiring hospitalization confirms a diagnosis of bipolar I disorder. In bipolar depression, using agents like quetiapine or lurasidone safely and effectively treats the depressive symptoms without carrying the high risk of a manic switch associated with traditional antidepressants.

Adım Adım Çözüm

1
Identify the patient's primary diagnosis.
The patient has bipolar I disorder, currently in a depressive episode.
The presentation of a major depressive episode combined with a clear history of a distinct manic episode (hospitalization for pressured speech, grandiosity, and insomnia) confirms bipolar I disorder.
2
Determine appropriate first-line therapies for acute bipolar depression.
Quetiapine and lurasidone are among the correct choices.
These specific second-generation antipsychotics are FDA-approved and highly efficacious for treating bipolar depression without significantly increasing the risk of manic switching.
3
Rule out contraindicated pharmacological therapies.
Antidepressant monotherapy and dangerous drug combinations must be avoided.
Antidepressant monotherapy can precipitate a manic episode in bipolar patients. Furthermore, combining an SSRI with an MAOI causes life-threatening serotonin syndrome.

Anahtar Kavram

Pharmacological management of acute bipolar depression
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Bipolar and Related Disorders

Bu konudan daha fazla soru